(ALNY) Alnylam - Performance 65.7% in 12m
Compare ALNY with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
46.52%
#11 in Group
Rel. Strength
93.31%
#536 in Universe
Total Return 12m
65.65%
#20 in Group
Total Return 5y
69.57%
#23 in Group
P/E -
(?) Percentile in Group
P/E Forward 833
98th Percentile in Group
PEG -0.49
22th Percentile in Group
FCF Yield -0.15%
80th Percentile in Group
12m Total Return: ALNY (65.7%) vs XBI (-6.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: ALNY vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ALNY
Total Return (including Dividends) | ALNY | XBI | S&P 500 |
---|---|---|---|
1 Month | -16.76% | -10.94% | -6.73% |
3 Months | -12.18% | -14.92% | -11.93% |
12 Months | 65.65% | -6.46% | 7.24% |
5 Years | 69.57% | -19.21% | 100.61% |
Trend Score (consistency of price movement) | ALNY | XBI | S&P 500 |
1 Month | -71.0% | -52.8% | -63.5% |
3 Months | -62.3% | -92.8% | -90.3% |
12 Months | 31.2% | -32.4% | 60.6% |
5 Years | 68.0% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #135 | -6.53% | -10.8% |
3 Month | #63 | 3.22% | -0.29% |
12 Month | #19 | 77.1% | 54.5% |
5 Years | #25 | 110% | -15.5% |
FAQs
Does ALNY Alnylam outperforms the market?
Yes,
over the last 12 months ALNY made 65.65%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months ALNY made -12.18%, while XBI made -14.92%.
Over the last 3 months ALNY made -12.18%, while XBI made -14.92%.
Performance Comparison ALNY vs Indeces and Sectors
ALNY vs. Indices ALNY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 3.12% | -10.0% | -11.2% | 58.4% |
US NASDAQ 100 | QQQ | 2.64% | -9.40% | -11.3% | 58.1% |
US Dow Jones Industrial 30 | DIA | 5.15% | -9.85% | -11.8% | 61.2% |
German DAX 40 | DAX | 1.90% | -12.8% | -31.1% | 45.3% |
Shanghai Shenzhen CSI 300 | CSI 300 | 3.69% | -13.4% | -12.3% | 56.4% |
Hongkong Hang Seng | HSI | 0.45% | -13.0% | -15.7% | 48.9% |
India NIFTY 50 | INDA | 0.97% | -18.8% | -14.5% | 62.7% |
Brasil Bovespa | EWZ | -1.15% | -17.2% | -16.2% | 74.4% |
ALNY vs. Sectors ALNY is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 2.41% | -9.91% | -20.3% | 50.6% |
Consumer Discretionary | XLY | 1.68% | -9.92% | -16.5% | 54.4% |
Consumer Staples | XLP | 2.97% | -19.7% | -19.1% | 54.3% |
Energy | XLE | 3.05% | -4.26% | -9.87% | 78.4% |
Financial | XLF | 2.42% | -11.9% | -20.0% | 47.8% |
Health Care | XLV | 5.39% | -9.00% | -8.95% | 68.0% |
Industrial | XLI | 3.72% | -10.7% | -11.0% | 61.6% |
Materials | XLB | 3.38% | -10.9% | -3.91% | 71.6% |
Real Estate | XLRE | 3.35% | -13.5% | -10.8% | 50.9% |
Technology | XLK | 2.85% | -7.76% | -4.93% | 64.5% |
Utilities | XLU | 3.23% | -17.0% | -14.8% | 44.0% |
Aerospace & Defense | XAR | 4.57% | -13.6% | -20.5% | 43.8% |
Biotech | XBI | -0.30% | -5.82% | 0.23% | 72.1% |
Homebuilder | XHB | 1.59% | -8.64% | 3.59% | 76.2% |
Retail | XRT | 1.25% | -11.4% | -7.73% | 71.9% |